Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study
Noura F.M. El Hamaky, Abdelrahman Hamdi, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107437-107437
Closed Access | Times Cited: 10

Showing 10 citing articles:

Development of 1,2,3-triazole hybrids as multi-faced anticancer agents co-targeting EGFR/mTOR pathway and tubulin depolymerization
Mennatallah A. Shaheen, Khaled M. Darwish, Safaa M. Kishk, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108153-108153
Closed Access
Design, synthesis, and in silico studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects
Aisha A. Alsfouk, Ismail M. M. Othman, Manal M. Anwar, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 1407-1424
Open Access
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study
Wafaa A. Ewes, Samar S. Tawfik, Aya M. Almatary, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3186-3186
Open Access | Times Cited: 5
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 4
Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents
Heba Adawy, Samar S. Tawfik, Abdullah A. Elgazar, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35239-35254
Open Access
Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access
Unveiling the potential anticancer activity of new dihydropyrimidines through dual inhibition of EGFR and TrkA: Design, synthesis, and in silico study
Aya M Slly, Wafaa A. Ewes, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107962-107962
Closed Access
Development of Novel 1,2,3‐Triazole‐Benzoxazole Hybrids as an E. coli DNA Gyrase B Inhibitor: Design, Synthesis, in Silico, and in Vitro Antimicrobial Evaluation
Jigarkumar V. Mendapara, Mahesh D. Vaghasiya, Mohit Agrawal, et al.
ChemistrySelect (2024) Vol. 10, Iss. 1
Closed Access
The current landscape of 1,2,3‐triazole‐(fused) six‐membered nitrogen‐containing heteroaromatic ring hybrids with anticancer therapeutic potential
Zhi Xu, Rongqiang Li, Zhiwei Huang, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Page 1

Scroll to top